Floxuridine Synthesis via Acid-Catalyzed Coupling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing floxuridine (FUDR) are inefficient, produce significant impurities, and lack scalability, which hinders the production of its derivative NUC-3373, an effective anticancer drug.
Innovation Solution
A novel process involving specific acid and solvent combinations, such as using sulfonic acids like p-toluenesulfonic acid and dichloromethane, at controlled temperatures (9°C to 15°C), to achieve high diastereoisomeric purity of FUDR, thereby enhancing the yield and reducing impurities, and subsequently converting it to NUC-3373.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional synthesis methods are used to produce FUDR, then the production process is simple, but the yield is low and impurity levels are high
Solution Approach 1:
The patent applies parameter changes by optimizing reaction temperature (9-15°C), acid catalyst type (p-toluenesulfonic acid), and solvent selection (dichloromethane) to achieve high diastereoisomeric purity (>95%) and improved yield. These specific parameter modifications resolve the contradiction between simple production and high quality output.
2Manufacturing precision
If multi-step synthesis routes are used, then more conversion steps are available, but the process becomes more complex and less scalable
Solution Approach 1:
The patent segments the synthesis process into a single optimized coupling step using protected ribofuranosyl chloride and 2,4-bis(trimethylsilyloxy)-5-fluoropyrimidine, eliminating the need for multiple steps while achieving >95% diastereoisomeric purity through controlled reaction conditions.
Solution Approach 2:
The patent employs preliminary action by using pre-protected ribofuranosyl chloride with specific protecting groups that enable direct coupling to form the β-anomer selectively, avoiding subsequent purification steps and simplifying the overall process.
3Speed
If higher reaction temperatures are used, then reaction rate increases, but diastereoisomeric purity decreases due to increased impurity formation
Solution Approach 1:
The patent changes the temperature parameter to a specific range (9-15°C) that balances reaction rate with diastereoisomeric purity. This optimized temperature prevents impurity formation while maintaining acceptable reaction speed, resolving the contradiction between speed and precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process significantly improves the yield and purity of FUDR and its conversion to NUC-3373, overcoming the inefficiencies of prior methods and providing a more effective anticancer agent with enhanced selectivity and tolerance.
Implementation Method 1
reacting a compound of Formula Ia with a compound of Formula IIa in the presence of an acid A1 to provide a compound of Formula IIIa
Data Source
AI summary
The present invention relates to a process for the preparation of floxuridine, said process comprising reacting a compound of Formula la with a compound of Formula lla in the presence of an acid Al to provide a compound of Formula Ilia in substantially diastereomerically pure form. Floxuridine may be useful as an anti-cancer drug. Floxuridine may also be useful in the preparation of other anti-cancer drugs, e.g. NUC-3373.